Md Ariful Haque
Impact in
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 26
- Chronic Myeloid Leukemia Treatments 24
- Genetics 24
- Chronic Lymphocytic Leukemia Research 21
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Co-authors
- Andreas Hochhaus (17 shared papers)Hagop Kantarjian (19 shared papers)Neil J. Gallagher (17 shared papers)Giuseppe Saglio (11 shared papers)Timothy P. Hughes (11 shared papers)Dong‐Wook Kim (11 shared papers)Richard A. Larson (9 shared papers)Albert Hoenekopp (3 shared papers)
- Journals
- Blood (21 papers)International Journal of Surgery (5 papers)F1000Research (3 papers)Journal of Clinical Oncology (2 papers)Annals of Medicine and Surgery (16 papers)
- Partner nations
- BangladeshChinaPakistan
In The Last Decade
Md Ariful Haque
77 papers receiving 3.0k citations
Md Ariful Haque's Hit Papers
Peers
Comparison fields: 5 of 115
- Hematology 2.4k
- Genetics 1.6k
- Rheumatology 1.1k
- Health 96
- Oncology 293
Countries citing papers authored by Md Ariful Haque
This map shows the geographic impact of Md Ariful Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md Ariful Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md Ariful Haque more than expected).
Fields of papers citing papers by Md Ariful Haque
This network shows the impact of papers produced by Md Ariful Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md Ariful Haque. The network helps show where Md Ariful Haque may publish in the future.
Co-authors
The 25 scholars most cited alongside Md Ariful Haque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia Hit paper breakdown → | 2010 | 1381 |
| 2 | Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance Hit paper breakdown → | 2007 | 604 |
| 3 | 2009 | 263 | |
| 4 | 2012 | 86 | |
| 5 | 2021 | 71 | |
| 6 | 2020 | 65 | |
| 7 | 2021 | 47 | |
| 8 | 2010 | 37 | |
| 9 | 2008 | 36 | |
| 10 | 2007 | 30 | |
| 11 | 2009 | 30 | |
| 12 | 2008 | 27 | |
| 13 | 2007 | 24 | |
| 14 | Comparative study between combination of famciclovir and prednisolone with prednisolone alone in acute Bell's palsy. | 2011 | 20 |
| 15 | 2007 | 19 | |
| 16 | 2006 | 19 | |
| 17 | 2022 | 18 | |
| 18 | 2008 | 17 | |
| 19 | 2007 | 16 | |
| 20 | 2008 | 16 |
About Md Ariful Haque
Md Ariful Haque is a scholar working on Hematology, Genetics, Rheumatology, Modeling and Simulation and Epidemiology, having authored 90 papers that have together received 3.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (24 papers), Chronic Lymphocytic Leukemia Research (21 papers), Eosinophilic Disorders and Syndromes (6 papers), COVID-19 epidemiological studies (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Vaccine Coverage and Hesitancy (5 papers), COVID-19 and Mental Health (4 papers) and Surgical Simulation and Training (3 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (1.6k citations), Rheumatology (1.1k citations), Health (96 citations) and Oncology (293 citations). Md Ariful Haque has collaborated with scholars based in Bangladesh, China and Pakistan. Frequent co-authors include Andreas Hochhaus, Hagop Kantarjian, Neil J. Gallagher, Giuseppe Saglio, Timothy P. Hughes, Dong‐Wook Kim, Richard A. Larson, Albert Hoenekopp, Ricardo Anibal Pasquini and Richard E. Clark. Their work appears in journals such as Blood, International Journal of Surgery, F1000Research, Journal of Clinical Oncology and Annals of Medicine and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.